Sort
261,768 grants matching “gene therapy”
Primary Immune Deficiency Treatment Consortium
$1,233,108Morton Cowan · University Of California, San Francisco · U54 · FY2010 · AI
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
$1,233,079Harold A Chapman · University Of California, San Francisco · U01 · FY2019 · HL
Interventional approaches for restoring vision
$1,233,046Anand Swaroop · National Eye Institute · ZIA · FY2010 · EY
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$1,233,032Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Core 3 - Immunobiology Core
$1,232,994Derek Wilson Cain · Duke University · U54 · FY2022 · AI
P1 - Molecular Mechanisms of KIT Signaling and Imatinib Resistance in GIST
$1,232,964Cristina R Antonescu · Sloan-Kettering Inst Can Research · P50 · FY2012 · CA
Molecular Mechanisms of HIV Latency
$1,232,907Eric M Verdin · J. David Gladstone Institutes · R01 · FY2016 · DA
Engineered HSV For Treatment of Malignant Glioma
$1,232,894Richard J. Whitley · University Of Alabama At Birmingham · P01 · FY2013 · CA
Genomic Architecture of Progression and Treatment Response in AMD
$1,232,793Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2015 · EY
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,232,770Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Extending the Phenotype of Nonsyndromic Orofacial Clefts
$1,232,714Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DE
BEHAVIORAL GENOMICS OF ALCOHOL NEUROADAPTATION
$1,232,629Tamara J. Phillips · Oregon Health & Science University · P60 · FY2016 · AA
Molecular Genetics Of Mammalian Retrovirus Replication
$1,231,898Judith G Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
TEXAS CANCER GENETICS CONSORTIUM
$1,231,684University Of Texas Md Anderson Can Ctr · U24 · FY2001 · CA
TNF Signaling, Cell Death and Cancer
$1,231,658Zheng-Gang Liu · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center
$1,231,641Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2022 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,231,558Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
SCOR IN MOLECULAR MEDICINE AND ATHEROSCLEROSIS
$1,231,515Weill Medical College Of Cornell Univ · P50 · FY2001 · HL
Immunobiology of Tolerance FF Allogeneic Hematopoietic Cell Transplantation
$1,231,495John Andrew Hansen · Fred Hutchinson Cancer Research Center · P01 · FY2011 · AI
Pathway inhibitors in Lymphomas
$1,231,483Mark Roschewski · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
The Boston Lung Cancer Survival Cohort
$1,231,212David C Christiani · Harvard School Of Public Health · U01 · FY2023 · CA
Transcription Regulation In Vertebrate Eye Development
$1,231,114Heinz Arnheiter · Neurological Disorders And Stroke · Z01 · FY2007 · NS
A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization
$1,231,107William Coulis Jason Hunter · Pet/X, Llc · R42 · FY2020 · CA
Mechanism of Latency of Herpes Simplex Virus
$1,230,982Nigel William Fraser · University Of Pennsylvania · P01 · FY2010 · NS
Regulation of Adult Mesenchymal Stem Cells
$1,230,924Rocky S. Tuan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2009 · AR